2(E)-(4-bromophenyl)ethenesulfonyl chloride

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2(E)-(4-bromophenyl)ethenesulfonyl chloride
• 英文别名: 2-(4-Bromophenyl)ethenesulfonyl chloride；2-(4-bromophenyl)ethenesulfonyl chloride
• 化学式: C₈H₆BrClO₂S
• mdl: MFCD12192926
• 分子量: 281.557
• InChiKey: QAAQAKSRVIIUEV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2(E)-(4-bromophenyl)ethenesulfonyl chloride 生成 4-[2(E)-(4-bromophenyl)ethenesulfonyl]-1-[1-(4-pyridyl)-4-piperidinylamino]-2-piperazinone
  参考文献：
  名称：

  ACYLHYDRAZINE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND USE THEREOF

  摘要：

  公开号：

  EP1188755B1

文献信息

• Bis-(Sulfonylamino) Derivatives in Therapy 205
  申请人：Bylund Johan

  公开号：US20090163586A1

  公开（公告）日：2009-06-25

  The invention provides compounds of formula (I) wherein R 1 , R 3 , L 1 , L 2 , G 1 , G 2 , A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

  该发明提供了式（I）的化合物 其中R 1 ，R 3 ，L 1 ，L 2 ，G 1 ，G 2 ，A和m如规范中定义的那样，以及其光学异构体，消旋体和互变异构体，以及其药学上可接受的盐；以及它们的制备方法，含有它们的药物组合物以及它们在治疗中的应用。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。
• One-pot, three-component synthesis of novel δ-sultam scaffolds via N-sulfonylation—intramolecular Michael sequences
  作者：Mehdi Ghandi、Seyed Hadi Nazari、Abolfazl Hasani Bozcheloei、Masoud Sadeghzadeh、Reza Kia

  DOI：10.1016/j.tetlet.2011.09.146

  日期：2011.12

  The synthesis of novel δ-sultam scaffolds utilizing one-pot, three-component reactions of 1,3-dicarbonyl compounds, primary aliphatic amines and substituted styrenesulfonyl chlorides is reported. A variety of six-membered sultams are obtained in moderate to good yields presumably via N-sulfonylation—intramolecular Michael addition sequences.

  报道了利用1，3-二羰基化合物，伯脂肪族胺和取代的苯乙烯磺酰氯的一锅，三组分反应合成新型δ-sultam支架的方法。大概是通过N-磺酰化-分子内迈克尔加成序列，以中等到良好的产率获得了多种六元的阿马甜。
• Palladium-Catalyzed Asymmetric Addition of Diarylphosphines to α,β-Unsaturated Sulfonic Esters for the Synthesis of Chiral Phosphine Sulfonate Compounds
  作者：Junzhu Lu、Jinxing Ye、Wei-Liang Duan

  DOI：10.1021/ol402351c

  日期：2013.10.4

  Highly stereoselective addition of diarylphosphines to α,β-unsaturated sulfonic esters catalyzed through a PCP pincer–Pd complex is developed to synthesize chiral phosphine sulfonic esters with excellent enantioselectivity (up to 99.5% ee). The transformation of the chiral adduct into a useful palladium phosphine sulfonate complex is also demonstrated.

  开发了通过PCP夹钳-Pd络合物催化的二芳基膦高立体选择性加成到α，β-不饱和磺酸酯上，以合成具有出色对映选择性（高达99.5％ee）的手性膦磺酸酯。还证明了手性加合物向有用的膦膦磺酸钯络合物的转化。
• Palladium-Catalyzed Asymmetric 1,4-Addition of Diarylphosphines to α,β-Unsaturated Sulfonamides
  作者：Fanhua Xiao、Wei-Liang Duan、Guo-Fa Dai、Yu-Chuan Song

  DOI：10.1055/s-0036-1591593

  日期：2018.9

  Abstract A pincer palladium-catalyzed asymmetric 1,4-addition of diarylphosphines to α,β-unsaturated sulfonamides was realized for the synthesis of chiral sulfonamide phosphines with up to 98% ee under mild conditions. A pincer palladium-catalyzed asymmetric 1,4-addition of diarylphosphines to α,β-unsaturated sulfonamides was realized for the synthesis of chiral sulfonamide phosphines with up to 98%

  摘要 实现了在温和的条件下，钯在α，β-不饱和磺酰胺上钯催化的不对称1,4-加成反应，从而合成了手性磺酰胺膦，其ee高达98％。 实现了在温和的条件下，钯在α，β-不饱和磺酰胺上钯催化的不对称1,4-加成反应，从而合成了手性磺酰胺膦，其ee高达98％。
• Imidazole derivative, process for producing the same, and use
  申请人：Kubo Keiji

  公开号：US20070004736A1

  公开（公告）日：2007-01-04

  There is provided an imidazole derivative useful as a thrombosis treating agent, which is represented by the formula (I): wherein R represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent linear hydrocarbon group, X represents an optionally substituted divalent hydrocarbon group, Y represents —CO—, —S(O)—, —S(O) 2 — or a bond, ring A represents an optionally substituted pyrrolidine ring, an optionally substituted piperidine ring or an optionally substituted perhydroazepine ring, Z 1 and Z 3 independently represent a bond or an optionally substituted divalent linear hydrocarbon group, Z 2 represents —N(R 1 )—, —O—, —S(O)—, —S(O) 2 —, —CO—, —CH(R 1 )— or a bond, ring B represents an optionally substituted imidazole ring, wherein a substituent which the optionally substituted imidazole ring represented by ring B may have may be taken together with R 1 to form an optionally substituted ring, and a represents 0, 1 or 2.

  提供了一种咪唑衍生物，用作治疗血栓的药物，其化学式表示为(I)式：其中R代表可选取代的环烃基或可选取代的杂环基，W代表键或可选取代的二价直链烃基，X代表可选取代的二价烃基，Y代表-CO-、-S(O)-、-S(O)2-或键，环A代表可选取代的吡咯烷环、可选取代的哌啶环或可选取代的过氢杂环己烷环，Z1和Z3独立地代表键或可选取代的二价直链烃基，Z2代表-N(R1)-、-O-、-S(O)-、-S(O)2-、-CO-、-CH(R1)-或键，环B代表可选取代的咪唑环，其中可选取代的咪唑环所具有的取代基可以与R1一起形成可选取代的环，a代表0、1或2。